InvestorsHub Logo
Followers 11
Posts 292
Boards Moderated 0
Alias Born 03/11/2011

Re: chickpea598 post# 40803

Tuesday, 10/31/2017 11:27:13 PM

Tuesday, October 31, 2017 11:27:13 PM

Post# of 48316
they are related, look below under relatives. https://www.mylife.com/mitchell-kopin/e454951875768 Jordyn works in New York at Cogent, so it is her. He knows exactly what he is investing in, since he also has a 5.2% on Celsion. He must really like IL-12 and knows why it will be needed as a base for combinations. However, Oncosec has the advantage of utilizing Electroporation vs their Vector of IL-12 and Oncosec is combining their IL-12 with Keytruda while Celsion is doing it with chemo. Also Oncosec has a more advanced study and a larger stake by Mitchell P. Kopin
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News